Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Rob Curran Shares of oncology drug developer Kintara Therapeutics plunged after it suspended development of a brain-cancer treatment candidate, shifted...
By Ben Glickman Shares of Ocular Therapeutix rose Tuesday after a trial of its drug Dextenza met its primary endpoint. The stock was up 15% to $2.85 in...
By Ben Glickman Tonix Pharmaceuticals will discontinue development of its treatment for major depressive disorder after a study of the drug failed to meet...
By Dean Seal Deciphera Pharmaceuticals said the Phase 3 study of its treatment vimseltinib for tenosynovial giant cell tumors met its primary endpoint and...
By Chris Wack Reviva Pharmaceuticals Holdings said Monday that it saw positive topline results and successful completion of its pivotal Phase 3 trial...